Clinical Education
Clinical Resource Materials for BD Neonatal ProductsClinical resource materials enhance knowledge and assist clinicians in optimizing patient care and reducing catheter-related complications.
Web Links
Vesely T., Stranz M., Masoorli S., Hadaway L.,The diverse and conflicting standards and practices in infusion therapy. JVAD, Fall 2002. Order #MISC532 "Insertion and management of vascular access devices require safe and consistent methods, and yet we frequently see inconsistency among documents written to guide the care that we provide. Standards of practice and practice guidelines are written by several organizations and therefore have differing recommendations. These documents are used as the basis for developing internal standards with each facility, so confusion about many aspects of care may be the end result.This review of standards and practices focuses on tip positioning of central venous catheters, the pH and osmolality of IV medications and solutions being delivered via venous access devices, assessing the functioning of devices prior to infusion of solutions, and the evolution of evidence-based practice. To receive a complimentary copy of the complete article #MISC532, send an email to infusion_marketing@bd.com or call 1-800-227-2918 Pettit, J., Hughes, K. Neonatal Intravenous Therapy Practices. JVAD, Spring 1999, pgs. 7-16. "Variations in neonatal IV therapy practice are commonplace. It is imperative that all medical care providers become educated in intravenous therapy and vascular device options. Improvement in vascular access technology, with enhanced short-term catheter materials and peripherally inserted central catheters, may offer this vulnerable population additional options for vascular access, with fewer complications and prolonged catheter indwelling periods." To order reprints, contact the AVA office at 1-877-924-2821 or visit the AVA website at www.avainfo.org. Pettit, J. Challenges to providing vascular access in neonatal patients. JVAD, Spring 2000, pgs. 16-21. Order #555 "When you consider what the nursing staff does and needs to accomplish in a neonatal intensive care unit (NICU), everything is viewed as a challenge. One of the biggest challenges in the NICU is that there is little evidence to support what we are doing on a day-to-day basis to treat these patients. While our body of knowledge is growing every year, we tend to take what works for adults and then try and make it work for babies. Intravenous therapy is an important part of providing care for these infants, but there are a few "myths" about IV therapy that impact treatment of these patients. These myths concern device selection, use of appropriate IV medications and solutions, and removal of devices." To receive a complimentary copy of the complete article, contact your BD Sales Consultant and ask for order #555 or send an email to infusion_marketing@bd.com. If you do not know who your BD Sales Consultant is, please call 1-888-237-2762. Pettit, J. Advances in Neonatal Care - Assessment of the infant with a peripheral intravenous device. NANN, Vol.3 - Number 5, October 2003, pgs. 230-240 Order #MISC534 "Inserting, monitoring, and maintaining peripheral venous access is an integral component of neonatal nursing care. Although complications associated with peripheral vascular devices are typically minor, some infants may experience life-threatening sequelae or serious and prolonged alterations in function. This article provides a review of the relevant anatomy and physiology of the peripheral venous system, techniques for maintaining catheter security, and guidelines for conducting a systematic physical assessment. The most commonly occurring complications, such as infiltration, phlebitis, and occlusion, are described. The etiology of the complications, signs and symptoms, and key evidence-based prevention strategies outlined." To receive a complimentary copy of the complete article #N2003, send an email to infusion_marketing@bd.com or call 1-800-227-2918. Stanley M., Meister E., Fuschuber K., Infiltration During Intravenous Therapy in Neonates: Comparison of Teflon® and Vialon™ Catheters. Southern Medical Journal, September 1992, Vol. 85, No. 9, pgs. 883-886. Order #MISC507 "Infiltration is a frequent complication of intravenous therapy using peripheral venous lines in neonatal patients. In a randomized trial of two catheter materials, Vialon (Becton Dickinson) and Teflon (DuPont), we studied 19 putative risk factors for infiltration, including 11 infusates, in 772 peripheral venous lines in patients aged 1 to 67 days. The multivariate models showed that Vialon catheter material reduced the risk of infiltration by 18% in the total sample and by 35% in the higher risk low-weight (< 1500 g) subsample." To receive a complimentary copy of the article above, contact your BD Sales Consultant and ask for Order #MISC507 or send an email to infusion_marketing@bd.com. If you do not know who your BD Sales Consultant is, please call 1-888-237-2762. Maki, D. & Ringer, M. Risk Factors for Infusion-related Phlebitis with Small Peripheral Venous Catheters. Annals of Internal Medicine, Vol. 114, No. 10, 15 May 1991. Order #MISC508 "Multiple factors, including the infusate and the duration of cannulation, contribute to the development of infusion-related phlebitis. The use of peripheral intravenous catheters made of PEU-Vialon appears to pose the same risk for catheter-related infection as the use of catheters made of FEP-Teflon, and PEU-Vialon can permit longer cannulation with less risk for phlebitis." To receive a complimentary copy of the article above, contact your BD Sales Consultant and ask for Order #543 or send an email to infusion_marketing@bd.com. If you do not know who your BD Sales Consultant is, please call 1-888-237-2762.
|